Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BBCA Group, also known as Fengyuan Group, is a large-scale Chinese industrial conglomerate specializing in biochemical engineering and pharmaceutical manufacturing. Headquartered in Bengbu, Anhui, the company is recognized as one of the world's leading producers of citric acid and amino acids, utilizing advanced fermentation technologies. Its pharmaceutical arm, BBCA Pharmaceutical, maintains a robust portfolio of active pharmaceutical ingredients (APIs) and finished dosage forms, including large-volume parenterals and various oral medications. The group operates an integrated industrial chain that spans from agricultural processing to high-value life science products and biodegradable materials like polylactic acid. BBCA Group serves both domestic and international markets, providing essential medical supplies and biochemical components to the global healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BBCA Group.